Lv11
40 积分 2022-09-07 加入
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
6小时前
已完结
503LBA LBA Orals: Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)
9天前
已完结
Global, regional and national burden of primary liver cancer by subtype
14天前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
1个月前
已完结
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
2个月前
已完结
Ocular toxicities associated with antibody drug conjugates and immunotherapy in oncology: clinical presentation, pathogenesis, and management strategies
2个月前
已完结
EGFR-mutated NSCLC: A roadmap to treatment sequences
2个月前
已关闭
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
2个月前
已完结
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
